Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:18
04/18/24
04/18
11:18
04/18/24
11:18
ITCI

Intra-Cellular

$73.15 /

-3.52 (-4.59%)

, SNGX

Soligenix

/

+

, MRNS

Marinus Pharmaceuticals

$1.47 /

+0.03 (+2.08%)

, BHVN

Biohaven

$41.68 /

-2.37 (-5.38%)

, JAGX

Jaguar Health

/

+

, NCNA

NuCana

$4.05 /

-0.1 (-2.41%)

, CRBP

Corbus Pharmaceuticals

$37.26 /

-0.095 (-0.25%)

, NTLA

Intellia Therapeutics

$21.80 /

+0.29 (+1.35%)

These names in the…

Open Full Text

Over a month ago
Hot Stocks
Intellia Therapeutics announces first patient dosed in Phase 3 MAGNITUDE study » 07:38
03/18/24
03/18
07:38
03/18/24
07:38
NTLA

Intellia Therapeutics

$28.30 /

+0.8 (+2.91%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Editas Medicine price target raised by $5 at Citi, here's why » 06:28
02/29/24
02/29
06:28
02/29/24
06:28
EDIT

Editas Medicine

$11.08 /

+2.21 (+24.93%)

Citi raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Editas Medicine price target raised by $1 at Barclays, here's why » 05:45
02/29/24
02/29
05:45
02/29/24
05:45
EDIT

Editas Medicine

$11.08 /

+2.21 (+24.93%)

Barclays analyst Gena…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Editas Medicine files automatic mixed securities shelf 17:28
02/28/24
02/28
17:28
02/28/24
17:28
EDIT

Editas Medicine

$11.08 /

+2.21 (+24.93%)

 
Hot Stocks
Editas Medicine expects cash to fund operations into 2026 » 07:03
02/28/24
02/28
07:03
02/28/24
07:03
EDIT

Editas Medicine

$8.87 /

+0.8 (+9.92%)

Cash, cash equivalents,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Editas Medicine reports Q4 EPS (23c), consensus (54c) » 07:02
02/28/24
02/28
07:02
02/28/24
07:02
EDIT

Editas Medicine

$8.87 /

+0.8 (+9.92%)

Reports Q4 revenue $60M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Downgrade
Intellia Therapeutics just downgraded at Goldman Sachs, here's why » 09:18
02/23/24
02/23
09:18
02/23/24
09:18
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Goldman Sachs analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Guggenheim, here's why » 08:47
02/23/24
02/23
08:47
02/23/24
08:47
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Guggenheim analyst Debjit…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target raised by $1 at Canaccord, here's why » 07:22
02/23/24
02/23
07:22
02/23/24
07:22
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Canaccord raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Intellia Therapeutics reports Q4 EPS ($1.46), consensus ($1.45) » 07:35
02/22/24
02/22
07:35
02/22/24
07:35
NTLA

Intellia Therapeutics

$26.84 /

-0.34 (-1.25%)

"We're off to a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Baird, here's why » 07:14
02/16/24
02/16
07:14
02/16/24
07:14
NTLA

Intellia Therapeutics

$28.44 /

+0.16 (+0.57%)

, ALNY

Alnylam

$147.48 /

-16.66 (-10.15%)

Baird lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics to develop genomic medicines for CF » 07:43
02/15/24
02/15
07:43
02/15/24
07:43
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics and…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics announce collaboration » 07:36
02/15/24
02/15
07:36
02/15/24
07:36
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Intellia Therapeutics initiated with neutral view at Wolfe Research, here's why » 19:23
02/14/24
02/14
19:23
02/14/24
19:23
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Intellia Therapeutics initiated with neutral view at Wolfe Research » 16:16
02/14/24
02/14
16:16
02/14/24
16:16
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Cathie Wood's ARK Investment bought 131K shares of Intellia Therapeutics today 20:04
02/05/24
02/05
20:04
02/05/24
20:04
NTLA

Intellia Therapeutics

$24.83 /

-0.45 (-1.78%)

 
Hot Stocks
Intellia Therapeutics announces publication of NTLA-2002 data in NEJM » 17:02
01/31/24
01/31
17:02
01/31/24
17:02
NTLA

Intellia Therapeutics

$23.81 /

-0.78 (-3.17%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 13:15
01/30/24
01/30
13:15
01/30/24
13:15
MREO

Mereo BioPharma

$3.84 /

-0.215 (-5.30%)

, ARWR

Arrowhead

$33.23 /

-1.195 (-3.47%)

, BEAM

Beam Therapeutics

$26.00 /

-2.3 (-8.13%)

, NTLA

Intellia Therapeutics

$24.83 /

-1.35 (-5.16%)

, VRTX

Vertex Pharmaceuticals

$443.94 /

+8.01 (+1.84%)

Biotech Analysts Kluska…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 10:55
01/30/24
01/30
10:55
01/30/24
10:55
MREO

Mereo BioPharma

$3.98 /

-0.08 (-1.97%)

, ARWR

Arrowhead

$33.40 /

-1.025 (-2.98%)

, BEAM

Beam Therapeutics

$26.39 /

-1.91 (-6.75%)

, NTLA

Intellia Therapeutics

$25.34 /

-0.84 (-3.21%)

, VRTX

Vertex Pharmaceuticals

$435.12 /

-0.81 (-0.19%)

Biotech Analysts Kluska…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Recommendations
Intellia Therapeutics price target lowered by $13 at Stifel, here's why » 09:55
01/08/24
01/08
09:55
01/08/24
09:55
NTLA

Intellia Therapeutics

$28.16 /

-0.485 (-1.69%)

Stifel lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Editas Medicine highlights 2024 anticipated milestones, strategic priorities » 08:41
01/08/24
01/08
08:41
01/08/24
08:41
EDIT

Editas Medicine

$9.08 /

-0.46 (-4.82%)

Editas Medicine announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
The Smid-cap biotech stocks to own in 2024, according to Bernstein » 11:19
01/02/24
01/02
11:19
01/02/24
11:19
VRTX

Vertex Pharmaceuticals

$410.12 /

+2.95 (+0.72%)

, ALNY

Alnylam

$193.13 /

+1.645 (+0.86%)

, NTLA

Intellia Therapeutics

$31.64 /

+1.17 (+3.84%)

, BMRN

BioMarin

$97.97 /

+1.565 (+1.62%)

, BEAM

Beam Therapeutics

$28.03 /

+0.84 (+3.09%)

, ARWR

Arrowhead

$31.37 /

+0.76 (+2.48%)

, ALLO

Allogene Therapeutics

$3.53 /

+0.33 (+10.31%)

, IONS

Ionis Pharmaceuticals

$53.49 /

+2.91 (+5.75%)

Discussing the biotech…

Open Full Text

Recommendations
Editas Medicine price target raised by $7 at Evercore ISI, here's why » 08:22
12/14/23
12/14
08:22
12/14/23
08:22
EDIT

Editas Medicine

$10.42 /

+0.58 (+5.89%)

Evercore ISI raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
What You Missed On Wall Street This Morning » 12:06
12/13/23
12/13
12:06
12/13/23
12:06
PFE

Pfizer

$26.43 /

-2.15 (-7.52%)

, TSLA

Tesla

$229.95 /

-7.09 (-2.99%)

, TTWO

Take-Two

$161.94 /

+4.76 (+3.03%)

, IART

Integra LifeSciences

$40.83 /

-0.12 (-0.29%)

, JNJ

Johnson & Johnson

$153.93 /

-1.13 (-0.73%)

, VRTX

Vertex Pharmaceuticals

$395.85 /

+38.21 (+10.68%)

, EDIT

Editas Medicine

$10.07 /

+0.225 (+2.29%)

, MSFT

Microsoft

$374.38 /

+0.04 (+0.01%)

, HTZ

Hertz

$8.64 /

-0.235 (-2.65%)

, F

Ford

$10.87 /

-0.3 (-2.69%)

, INCY

Incyte

$64.04 /

+2.21 (+3.57%)

, ACAD

Acadia Pharmaceuticals

$28.42 /

+7.265 (+34.34%)

, PLAB

Photronics

$25.07 /

+3.44 (+15.90%)

, LUV

Southwest

$28.61 /

-1.7 (-5.61%)

, PAYO

Payoneer Global

$5.01 /

-0.31 (-5.83%)

, AAPL

Apple

$196.06 /

+1.42 (+0.73%)

, SPOT

Spotify

$198.28 /

-0.77 (-0.39%)

, SONY

Sony

$90.12 /

-0.255 (-0.28%)

, TWLO

Twilio

$71.00 /

-0.16 (-0.22%)

, X

U.S. Steel

$38.09 /

+1.705 (+4.69%)

, T

AT&T

$16.20 /

-0.21 (-1.28%)

, ASML

ASML

$722.06 /

+1.335 (+0.19%)

, REVG

REV Group

$18.58 /

+1.53 (+8.97%)

, CGNT

Cognyte

$5.52 /

-0.225 (-3.92%)

, LPTV

Loop Media

/

+

, ADBE

Adobe

$622.10 /

-11.48 (-1.81%)

, ABM

ABM

$50.72 /

+6.3 (+14.18%)

Get caught up quickly on…

Open Full Text

Hot Stocks
Editas Medicine, Vertex Pharmaceuticals enter license agreement for Cas9 » 09:02
12/13/23
12/13
09:02
12/13/23
09:02
EDIT

Editas Medicine

$9.84 /

-0.065 (-0.66%)

, VRTX

Vertex Pharmaceuticals

$357.64 /

+1.41 (+0.40%)

Editas Medicine (EDIT)…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Editas Medicine price target raised by $5 at Truist, here's why » 09:29
12/12/23
12/12
09:29
12/12/23
09:29
EDIT

Editas Medicine

$9.91 /

-0.59 (-5.62%)

Truist raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Editas Medicine to hold a pharmaceutical update conference call » 12:45
12/11/23
12/11
12:45
12/11/23
12:45
EDIT

Editas Medicine

$10.18 /

-0.315 (-3.00%)

Conference call to…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Editas presents new EDIT-301 safety and efficacy data in 17 patients » 12:02
12/11/23
12/11
12:02
12/11/23
12:02
EDIT

Editas Medicine

$10.10 /

-0.395 (-3.76%)

Editas Medicine announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Crispr Therapeutics price target raised to $57 from $50 at RBC Capital » 08:24
12/11/23
12/11
08:24
12/11/23
08:24
CRSP

Crispr Therapeutics

$64.50 /

-5.69 (-8.11%)

, VRTX

Vertex Pharmaceuticals

$349.91 /

-4.01 (-1.13%)

, BLUE

Bluebird Bio

$2.86 /

-1.945 (-40.52%)

, NTLA

Intellia Therapeutics

$29.02 /

-0.75 (-2.52%)

RBC Capital analyst Luca…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.